Company Description
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers.
Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.
Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health.
The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
| Country | United States |
| Founded | 2017 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,442 |
| CEO | Andrew Dudum |
Contact Details
Address: 2269 Chestnut Street, Suite 523 San Francisco, California 94123 United States | |
| Phone | 415 851 0195 |
| Website | hims.com |
Stock Details
| Ticker Symbol | HIMS |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1773751 |
| CUSIP Number | 433000106 |
| ISIN Number | US4330001060 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Andrew Dudum | Co-Founder, Chairman and Chief Executive Officer |
| Oluyemi Okupe | Chief Financial Officer |
| Mike Chi | Chief Operating Officer |
| Soleil Teubner Boughton J.D. | Chief Legal Officer and Corporate Secretary |
| Dr. Patrick Carroll M.D. | Chief Medical Officer and Director |
| Deborah M. Autor J.D. | Chief Policy Officer and Director |
| Irene A. Becklund | Senior Vice President, Controller and Principal Accounting Officer |
| Mohamed ElShenawy | Chief Technology Officer |
| Dr. Peter Stahl M.D. | Senior Vice President of Men's Reproductive and Sexual Health |
| Dr. Daniel Lieberman M.D. | Senior Vice President of Mental Health |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 24, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 23, 2026 | 10-K | Annual Report |
| Feb 23, 2026 | 8-K | Current Report |
| Feb 19, 2026 | 8-K | Current Report |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Jan 20, 2026 | 144 | Filing |
| Dec 22, 2025 | 144 | Filing |
| Dec 17, 2025 | 144 | Filing |
| Dec 17, 2025 | 144 | Filing |
| Dec 17, 2025 | 144 | Filing |